Cepheid Sees Increasing Competition in HAI Test Market as Q1 Revenues Rise 27 Percent | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Cepheid is expecting more molecular diagnostics competitors to jump into the hospital-acquired infection testing market, as the firm plans to develop additional tests for that segment.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.